Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-24Clinical Trial Update: XELOX for 4 Months Versus 6 Months in Gastric Cancer (LOMAC) [Phase 3]
Phase 3 trial comparing 4 months vs 6 months of XELOX chemotherapy in gastric cancer has completed.
-
CLINICAL_TRIALS trial_result · 2026-08-13Clinical Trial Results: A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating NC410 plus pembrolizumab in advanced/metastatic solid tumors with various MSI statuses; terminated with posted re…
-
CLINICAL_TRIALS trial_result · 2026-07-30Clinical Trial Results: Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial evaluating a combination of oxaliplatin, Xeloda (capecitabine), and cetuximab for first-line treatment of metastatic or unrese…
-
CLINICAL_TRIALS trial_result · 2026-07-23Clinical Trial Results: NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours [Phase 1, Phase 2]
Phase 1/2 trial results of NUC-3373 in combination with other agents in patients with advanced solid tumors; study status terminated with re…
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Update: Ramucirumab Plus FOLFIRI Versus Ramucirumab Plus Paclitaxel in Patients With Advanced or Metastatic Gastric Cancer, Who Failed One Prior Line of Palliative Chemotherapy [Phase 2, Phase 3]
Clinical trial comparing ramucirumab plus FOLFIRI versus ramucirumab plus paclitaxel in advanced or metastatic gastric cancer after one prio…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Results: Pembrolizumab Plus Ramucirumab in Metastatic Gastric Cancer [Phase 2]
Phase 2 trial results evaluating pembrolizumab in combination with ramucirumab for metastatic gastric cancer have been completed and results…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Dual-target CLDN18.2/HER2 CAR-NK Cells for Advanced Gastric/GEJ Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial is recruiting to evaluate CLDN18.2/HER2-targeted CAR-NK cells for advanced gastric cancer and advanced gastroesop…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients [Phase 1, Phase 2]
A Phase 1/2 clinical trial investigates peripheral blood lymphocytes engineered with a murine T-cell receptor targeting the G12V mutation in…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis
A clinical trial update describing a study on surgical approaches for Gastrointestinal Stromal Tumors, including tumor modeling and genomic …
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: AI Model for Early Gastric Cancer Diagnosis Using Endoscopic Imaging
This entry reports the recruitment status of a clinical trial studying an AI model for diagnosing early gastric cancer from endoscopic image…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Identification of Therapeutic Targets in Metastatic Gastric Cancer
This clinical trial update notes ongoing recruitment for a study aiming to identify therapeutic targets in metastatic gastric cancer.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Low-dose Immunotherapy in Metastatic and Locally Advanced Colorectal and Gastric MSI/dMMR Cancers [Phase 2]
Phase 2 clinical trial evaluating low-dose immunotherapy for metastatic and locally advanced colorectal and gastric MSI/dMMR cancers; curren…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction [Phase 2]
A Phase 2 clinical trial update evaluating serplulimab in combination with chemotherapy as neoadjuvant therapy for locally advanced gastric …
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor) [Phase 1, Phase 2]
This document reports a Phase 1/2 clinical trial evaluating the anti-CEACAM5 antibody-drug conjugate M9140 in adults with advanced solid tum…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
AstraZeneca is conducting a Phase 1/2 trial to evaluate the safety of AZD6750 in adults with select advanced or metastatic solid tumors; the…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Study for AZD4360 in Participants With Advanced Solid Tumours [Phase 1, Phase 2]
Phase 1/2 clinical trial of AZD4360 in adults with advanced solid tumors, including gastric cancer and gastroesophageal junction cancer, is …
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Long-term Follow-up Study of Subjects Enrolled in Clinical Trials of Cadonilimab (AK104)
A long-term follow-up study is being conducted for subjects enrolled in trials of Cadonilimab (AK104) for gastric cancer, with the study cur…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Adebrelimab Plus Apatinib Combined With SOX Regimen as Conversion Therapy for Gastric Cancer [Phase 2]
Phase 2 clinical trial evaluating conversion therapy for gastric cancer using the PD-1 inhibitor Adebrelimab plus Apatinib in combination wi…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors [Phase 1]
BeiGene is conducting a Phase 1 safety study to evaluate different doses of BG-68501 in participants with various advanced-stage cancers, an…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
The update details a study to collect solid tumor tissue from people undergoing biopsy or surgery for colorectal, gastric, cholangiocarcinom…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Immediate and Functional Results of Different Types of Reconstructions After Proximal Gastrectomy For Gastric and Esophagogastric Junction Cancer
This clinical trial update evaluates immediate and functional outcomes of different reconstruction methods after proximal gastrectomy for ga…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer [Phase 2]
Phase 2 trial evaluating atezolizumab with or without chemotherapy for locoregional MSI-H/dMMR gastric and gastroesophageal junction cancers…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Fruquintinib and Albumin-paclitaxel Combined With or Without PD-1 Antibody in 2nd-line Treatment of G/GEJ Adenocarcinoma
This clinical trial update describes a study evaluating fruquintinib plus albumin-bound paclitaxel with or without a PD-1 antibody as second…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors [Phase 1]
NiKang Therapeutics is conducting a Phase 1 study of NKT3964 in adults with advanced or metastatic solid tumors, and the trial is currently …
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas [Phase 3]
Phase 3 clinical trial investigating a combination of an immune checkpoint inhibitor for locally advanced or metastatic MSI/dMMR esogastric …